Filing Details

Accession Number:
0001209191-22-018864
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-15 17:01:09
Reporting Period:
2022-03-11
Accepted Time:
2022-03-15 17:01:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659323 Iterum Therapeutics Plc ITRM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1734033 M. Judith Matthews C/O Iterum Therapeutics Plc
Fitzwilliam Court, Fl. 1, Leeson Close
Dublin 2 L2
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-03-11 100,000 $0.00 128,632 No 4 A Direct
Ordinary Shares Disposition 2022-03-14 47,132 $0.38 81,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Share Units Disposition 2022-03-11 100,000 $0.00 100,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 No 4 M Direct
Footnotes
  1. Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
  2. Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
  3. On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022.